- Lobbying
- Lobbying by Association for Accessible Medicines
Lobbying Relationship
Bills mentioned
S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.2212: CREATES Act of 2017
Sponsor: Tom Marino (R-Pa.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
David Crane | Senior Policy Advisor, Senate Majority Leader/Senate Republican Leader Trent Lott, Professional Staff Senate Commerce Committee Chairman John McCain, LA/LD Senator Dan Coats |
David Crane Mr | LA/LD Senator Dan Coats, Prof Staff, Senate Commerce Committee (Chairman John McCain, Senior Policy Advisor, Majority Leader Trent Lott |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
U.S. House of Representatives
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Office of the Vice President of the United States
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate